Cellular Detoxification: Supporting Hepatic and Systemic Clearance

Cellular detoxification focuses on optimizing Phase I and Phase II liver detoxification pathways while neutralizing heavy metals and environmental toxins stored in adipose and neural tissue. Utilizing targeted intravenous glutathione, liposomal binders, and targeted amino acids, this protocol supports systemic toxin clearance and restores mitochondrial ATP production.

Consumer Safety

Detoxification protocols must be carefully titrated based on baseline renal and hepatic function. Overly aggressive detox can mobilize toxins faster than organs of elimination can process them. Physician oversight ensures safe clearance without electrolyte imbalances or Herxheimer reactions.

Candidacy Requirements

Recommended for patients presenting with systemic inflammation, chronic fatigue syndrome, brain fog, high heavy metal burden, or those undergoing comprehensive lifestyle optimization.

Timeline Expectations

Protocols typically run for 4 to 8 weeks, consisting of weekly IV infusions alongside daily oral binding agents. Incremental cognitive clarity and energy improvements are noted by week 3.

Potential Downtime

Zero downtime. Infusions are completed in-clinic in 45-60 minutes, allowing patients to resume full normal activity immediately.

Expected Results

Reduced systemic inflammation, improved mental sharpness, enhanced hepatic fat metabolism, and restored cellular energy production.

Clinical Risks

Mild transient fatigue, mild headache, or lightheadedness as toxins are mobilized, all of which are managed through adequate hydration and binder titration.